Miles Stuart Congreve

Person

  • Welwyn Garden City, GB

Patents Grantslast 30 patents

Patents Applicationslast 30 patents

  • Information Patent Application

    CGRP ANTAGONIST COMPOUNDS

    • Publication number 20250136616
    • Publication date May 1, 2025
    • Nxera Pharma UK Limited
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    PEPTIDE DERIVATIVES AND RELATED USES AS OREXIN AGONISTS

    • Publication number 20240360175
    • Publication date Oct 31, 2024
    • Centessa Pharmaceuticals (UK) Limited
    • Noel Michael O'BOYLE
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    H4 Antagonist Compounds

    • Publication number 20240317775
    • Publication date Sep 26, 2024
    • Giles Albert BROWN
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    ORAL GLP RECEPTOR AGONISTS

    • Publication number 20240270809
    • Publication date Aug 15, 2024
    • Heptares Therapeutics Limited
    • Giles Albert BROWN
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    GPR35 Agonist Compounds

    • Publication number 20240254093
    • Publication date Aug 1, 2024
    • Heptares Therapeutics Limited
    • Miles Stuart CONGREVE
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    SARS-COV-2 MPRO INHIBITOR COMPOUNDS

    • Publication number 20240217930
    • Publication date Jul 4, 2024
    • HEPTARES THERAPEUTICS LIMITED
    • Miles Stuart CONGREVE
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    4-(3-CYANOPHENYL)-6-PYRIDINYLPYRIMIDINE MGLU5 MODULATORS

    • Publication number 20240092754
    • Publication date Mar 21, 2024
    • Heptares Therapeutics Limited
    • John Andrew Christopher
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    SARS-COV-2 MPRO INHIBITOR COMPOUNDS

    • Publication number 20240083845
    • Publication date Mar 14, 2024
    • HEPTARES THERAPEUTICS LIMITED
    • Miles Stuart CONGREVE
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    PYRROLOPYRIMIDINE COMPOUNDS AND THEIR USES

    • Publication number 20240043428
    • Publication date Feb 8, 2024
    • Novartis AG
    • Gilbert BESONG
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    CYCLIC APELIN RECEPTOR AGONISTS

    • Publication number 20230382950
    • Publication date Nov 30, 2023
    • Heptares Therapeutics Limited
    • Giles Albert BROWN
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    LINEAR APELIN RECEPTOR AGONISTS

    • Publication number 20230382949
    • Publication date Nov 30, 2023
    • Heptares Therapeutics Limited
    • Giles Albert BROWN
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    MEDIUM- OR MACRO-CYCLIC BENZYL-SUBSTITUTED HETEROCYCLE DERIVATIVES...

    • Publication number 20230331720
    • Publication date Oct 19, 2023
    • Orexia Therapeutics Limited
    • Bruce LEFKER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    GLP RECEPTOR AGONISTS

    • Publication number 20230295260
    • Publication date Sep 21, 2023
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    GLP-1 RECEPTOR ANTAGONISTS

    • Publication number 20230279053
    • Publication date Sep 7, 2023
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    5-AMINO-8-(4-PYRIDYL)-[1,2,4]TRIAZOLO[4,3-C]PYRIMIDIN-3-ONE COMPOUN...

    • Publication number 20230271964
    • Publication date Aug 31, 2023
    • AstraZeneca AB
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    H4 ANTAGONIST COMPOUNDS

    • Publication number 20230167094
    • Publication date Jun 1, 2023
    • Heptares Therapeutics Limited
    • Miles Stuart CONGREVE
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    5-AMINO-8-(4-PYRIDYL)-[1,2,4]TRIAZOLO[4,3-C]PYRIMIDIN-3-ONE COMPOUN...

    • Publication number 20230146483
    • Publication date May 11, 2023
    • AstraZeneca AB
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    TRIAZOLONE COMPOUNDS

    • Publication number 20230146796
    • Publication date May 11, 2023
    • AstraZeneca AB
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    1,2,4-TRIAZINE-4-AMINE DERIVATIVES

    • Publication number 20230021177
    • Publication date Jan 19, 2023
    • Heptares Therapeutics Limited
    • Miles Stuart Congreve
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    PROSTAGLANDIN EP4 RECEPTOR ANTAGONIST COMPOUNDS

    • Publication number 20220411364
    • Publication date Dec 29, 2022
    • Heptares Therapeutics Limited
    • Miles Stuart Congreve
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    PHARMACEUTICAL COMPOUNDS

    • Publication number 20220380379
    • Publication date Dec 1, 2022
    • Heptares Therapeutics Limited
    • Charlotte Fieldhouse
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    CGRP ANTAGONIST COMPOUNDS

    • Publication number 20220306651
    • Publication date Sep 29, 2022
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    CGRP ANTAGONIST COMPOUNDS

    • Publication number 20220251110
    • Publication date Aug 11, 2022
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    SUBSTITUTED CYCLOHEXANES AS MUSCARINIC M1 RECEPTOR AND/OR M4 RECEPT...

    • Publication number 20220213034
    • Publication date Jul 7, 2022
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    OXEXIN 1 RECEPTOR ANTAGONISTS

    • Publication number 20220098165
    • Publication date Mar 31, 2022
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    4-(3-CYANOPHENYL)-6-PYRIDINYLPYRIMIDINE MGLU5 MODULATORS

    • Publication number 20220056009
    • Publication date Feb 24, 2022
    • Heptares Therapeutics Limited
    • John Andrew Christopher
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    MUSCARINIC RECEPTOR AGONISTS

    • Publication number 20220048928
    • Publication date Feb 17, 2022
    • Heptares Therapeutics Limited
    • Miles Stuart Congreve
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    OREXIN 1 RECEPTOR ANTAGONISTS

    • Publication number 20220041573
    • Publication date Feb 10, 2022
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    QUINOLINONE AND BENZOXAZINE DERIVATIVES AS MUSCARINIC M1 AND/OR M4...

    • Publication number 20220017504
    • Publication date Jan 20, 2022
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    CYCLOHEXAPEPTIDES AS SELECTIVE SOMATOSTATIN SST5 RECEPTOR AGONISTS

    • Publication number 20210363188
    • Publication date Nov 25, 2021
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE